Treatment of Polypoidal Choroidal Vasculopathy With Photodynamic Therapy Combined With Intravitreal Injections of Ranibizumab
Authors:
- Akitaka TsujikawaATAkitaka Tsujikawa
- Kenji YamashiroKYKenji Yamashiro
- Sotaro OotoSOSotaro Ooto
- Hiroshi TamuraHTHiroshi Tamura
- Atsushi OtaniAOAtsushi Otani
- Yoshihito NakayamaYNYoshihito Nakayama
- Nagahisa YoshimuraNYNagahisa Yoshimura
- 1 January 2012
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 153 (1) , 68-80.e1
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (21592256)
- Japan National Society for the Prevention of Blindness
This publication has 46 references indexed in Scilit:
- ONE-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHYRetina, 2011
- Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-upClinical Ophthalmology, 2010
- Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary studyBritish Journal of Ophthalmology, 2010
- Transitions of multifocal electroretinography following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathyDocumenta Ophthalmologica, 2009
- Short-Term Safety and Efficacy of a Single Intravitreal Bevacizumab Injection for the Management of Polypoidal Choroidal VasculopathyOphthalmologica, 2008
- Recurrence of polypoidal choroidal vasculopathy after photodynamic therapyJapanese Journal of Ophthalmology, 2008
- The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal VasculopathyKorean Journal of Ophthalmology, 2008
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE) IN PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES: UPDATERetina, 2005
- Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation.British Journal of Ophthalmology, 1996